Rules allow drug developers to list on the bourse before they sell any products to patients
Related Posts
Alibaba’s rivals on alert after China’s regulators hand out record fine
China To Launch $8.13B Environmental Protection Fund
Trump’s cold war tactics will not work with China
Announcement of Resolutions of the 39th Meeting of the Second Board of Directors of Fujian Aonong Biotechnology Group Co., Ltd.
Yoox Net-a-Porter open to Chinese partnerships
China’s capital controls dent inbound investment- The Middle East Meltdown and Global Risk
Google suspends Huawei from Android services
Shanghai index higher, boosted by developers- Will China join zero interest rate club?